CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 14 No. 3 3
 

NCI Addresses Tobacco- Related Cancers in Women

By ROY S. HERBST, MD, PhD
The University of Texas
M . D. Anderson Cancer Center
Houston, Texas
| March 1, 2005

BETHESDA, Maryland-A working group of the National Cancer Institute (NCI) has released a series of recommendations aimed at stimulating scientific research into tobacco-related cancers in women and translating discoveries into evidencebased interventions to prevent the cancers worldwide. The report, "Women, Tobacco, and Cancer: An Agenda for the 21st Century," noted that the incidence and mortality rates of smoking-related cancers in US women soared during the second half of the 20th century. Lung cancer mortality in women increased 600% between 1950 and 1997, making it the leading cause of cancer death in females. The NCI working group comprised experts from the institute, other federal agencies, nongovernment research institutions, and advocacy groups. Members drew in part on information contained in several recent reports, including the 2001 Surgeon General's report, "Women and Smoking," which highlighted the importance of gender-specific research into tobacco use and effects. The panel set several key goals for future research into tobacco-related cancers in women:

  • Increase our understanding of sex differences across the broad range of research on women, tobacco, and cancer.
  • Develop new and more effective interventions to prevent and treat tobacco use and environmental tobacco smoke exposure among women and girls, especially in populations at greatest risk; expand partnerships, networks, and innovative research platforms to ensure the widespread delivery of these interventions.
  • Improve national and global evaluation and surveillance of the health hazards related to tobacco use and ETS exposure, specifically, of women's and girls' knowledge, attitudes, and behaviors related to tobacco use and associated risks. The working group emphasized that there is a critical need to better understand sex differences as they relate to all phases of tobacco addiction and tobacco-related diseases. "This includes genetic, molecular, cellular, neurobiological, biobehavioral, and hormonal factors that play a critical role in tobacco addiction and in the etiology of cancers and other diseases caused by tobacco," the working group stated. Researchers also need to decipher the etiologic role of gene-hormoneenvironment interactions in the cancers, and discover new methods for prevention and treatment of tobacco addiction. In addition, the NCI panel said that development of better treatment and prevention techniques requires identifying the behavioral, psychosocial, sociocultural, and environmental factors that influence tobacco use, exposure to second-hand smoke, and disease risk.
Translating basic and applied research into effective interventions will depend on advances in four areas:
  • Using evidence from animal studies, pilot projects, and small clinical and community studies to develop new interventions for prevention, cessation, and treatment.
  • Finding ways to use or modify existing infrastructures to rapidly evaluate the efficacy of promising treatments and the effectiveness and costefficiency of proven small-scale programs and policies.
  • Exploring and strengthening the positive health effects of tobacco-control policies on women and girls.
  • Monitoring the harmful effects of tobacco marketing on females.
Delivering the proven results of research and development efforts will depend on finding ways to increase the appeal, access, affordability, and use of effective interventions, the working group said. This, in turn, will require identifying and targeting messages and strategies that successfully involve individuals and organizations in evidence-based tobacco-control policies. Data from research-including surveillance, policy, economic, and cultural studies-need to be more available to health care workers, policy makers, and the public, the panel added. The NCI report also stressed the importance of partnerships between government agencies, nongovernment organizations, private foundations, corporations, academic institutions, and community groups in accelerating progress in tobacco-related interventions aimed at women and girls. Finally, the panel cited the importance of local, national, and worldwide evaluation and surveillance in determining the progress of efforts to reduce tobacco use, ETS exposure, and tobacco-related cancers among women and girls, and to make changes in programs when needed.
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

ASCO to Create 'Blue Ribbon' Commission on Tobacco Problem ALEXANDRIA, Virginia-The American Society of Clinical Oncology (ASCO) is setting up an independent, blue ribbon commission to study the tobacco problem in all of its dimensions0-social, medical, legal, and economic, both domestically and globally. The commission, which will be made up of high-level representatives from government, educational and scientific organizations, advocacy groups, and the private sector, is in the primary developmental stages. Among the specific priority issues the commission will address are identifying appropriate schemes for regulating tobacco products, determining which federal agencies should take charge of tobacco control, and figuring out what scientific and medical research is required to better understand tobacco addiction.



An Annual Review of Lung Cancer


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • US Task Force Recommends Breast Cancer Medications for High-Risk Women
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy